Evidence map›Paper›PMID 28966725›Full record

ArticleGenes & cancer2017

PRAJA is overexpressed in glioblastoma and contributes to neural precursor development.

Joshua Shin, Viveka Mishra, Eric Glasgow, Sobia Zaidi, Jian Chen, Kazufumi Ohshiro, Bhargava Chitti, Amee A Kapadia, Neha Rana, Lopa Mishra and 3 more

Erratum issuedOpen access · diamondAbstract read
In one paragraph

Article in Genes & cancer, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Praja1 RING-finger E3 ubiquitin ligase is a common suppressor of neurodegenerative disease-associated protein aggregation.Neuropathology : official journal of the Japanese Society of Neuropathology · 2022
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 2 countries.

Joshua ShinUniversity of Virginia, Charlottesville, VA, USA.
Viveka MishraMassachusetts Institute of Technology, Cambridge, MA, USA.
Eric GlasgowDepartment of Molecular Oncology, Georgetown University, Washington DC, USA.
Sobia ZaidiCenter for Translational Medicine, Department of Surgery, George Washington University, Washington, DC, USA.
Jian Chen
Kazufumi OhshiroCenter for Translational Medicine, Department of Surgery, George Washington University, Washington, DC, USA.
Bhargava ChittiDepartment of Medicine, George Washington University, Washington, DC, USA.
Amee A KapadiaJohn Hopkins University, Department of Chemical and Biomolecular Engineering, Baltimore, MD, USA.
Neha RanaMcLean High School, McLean, VA, USA.
Lopa MishraCenter for Translational Medicine, Department of Surgery, George Washington University, Washington, DC, USA.
Chu-Xia DengFaculty of Health Sciences, University of Macau, Macau SAR, China.
Shuyun RaoCenter for Translational Medicine, Department of Surgery, George Washington University, Washington, DC, USA.
Bibhuti MishraCenter for Translational Medicine, Department of Surgery, George Washington University, Washington, DC, USA.
George Washington University · USGeorgetown University · USJohns Hopkins University · USMassachusetts Institute of Technology · USUniversity of Macau · MOUniversity of Virginia · US

Funding

Targeting CDK4 in TGS-B Inactivated Gastrointestinal CancersP01CA130821 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI REDDY, E PREMKUMAR · 2008 to 2013
$6.9M
Role of Beta Spectrin and Smad in Alcohol-Induced Liver and GI Cell ProliferationR01AA023146 · NIAAA · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Lopa Mishra · 2013 to 2026
$4.6M
METASTATIC POTENTIAL OF HUMAN COLORECTAL CARCINOMAR01CA042857 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI MISHRA, LOPA · 1986 to 2010
$3.2M
Gastrointestinal Cell Proliferation and Cell CycleR01CA106614 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI MISHRA, LOPA · 2005 to 2009
$1.5M
PRAJA-1: A NOVEL ANTI-APOPTOSIS RING FINGER PROTEINR01DK056111 · NIDDK · TEMPLE UNIVERSITY · PI MISHRA, LOPA · 1999 to 2003
$1.2M
Molecular Mechanisms and Translational studies in Colon CancerI01BX003732 · VA · U.S. DEPT/VETS AFFAIRS MEDICAL CENTER · PI MISHRA, LOPA · 2017 to 2019
–
BLRD VA I01 BX003732NCI NIH HHS P01 CA130821NCI NIH HHS R01 CA042857NCI NIH HHS R01 CA106614NIAAA NIH HHS R01 AA023146NIDDK NIH HHS R01 DK056111
6 · The paper itself

Abstract

PRAJA, a RING-H2 E3 ligase, is abundantly expressed in brain tissues such as the cerebellum and frontal cortex, amongst others, and more specifically in neural progenitor cells as well as in multiple cancers that include glioblastomas. However, the specific role that Praja plays in neural development and gliomas remains unclear. In this investigation, we performed bioinformatic analyses to examine Praja1 and Praja2 expression across 29 cancer types, and observed raised levels of Praja1 and Praja2 in gliomas with an inverse relationship between Praja1 and apoptotic genes and Praja substrates such as Smad3. We analyzed the role of Praja in the developing brain through loss of function studies, using morpholinos targeting Praja1 in embryonic zebrafish, and observed that Praja1 is expressed prominently in regions enriched with neural precursor cell subtypes. Antisense Praja morpholinos resulted in multiple embryonic defects including delayed neural development likely through increased apoptosis. Further studies revealed high levels of Cdk1 with loss of Praja1 in TGF-β or insulin treated cells, supporting the link between Praja1 and cell cycle regulation. In summary, these studies underscore Praja's role in mammalian brain development and Praja1 deregulation may lead to gliomas possibly through the regulation of cell cycle and/or apoptosis.

Indexed as

apoptosisglioblastomaPRAJA

Identifiers

PMID28966725
PMCPMC5620009
OpenAlexW2774591024

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.